In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

Measuring neurofilament light chain levels 48 hours after cardiac arrest can predict long-term cognitive impairment, outperforming current standard blood tests. This biomarker offers a new way for ...

Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Researchers say a simple blood test could help flag which older women face a higher risk of dementia long before any symptoms ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

PITTSBURGH — Earlier this month, the FDA approved another biomarker to help millions of patients and families affected by Alzheimer’s disease: a blood test that detects amyloid plaques, a hallmark of ...

Detecting the risk of Alzheimer's early is invaluable in taking the right steps to prevent the yet incurable disease, and one ...

It’s common to wait until something feels “off” before making an appointment to see a healthcare provider. But waiting for noticeable symptoms can mean missing the chance to catch health issues early.

Please provide your email address to receive an email when new articles are posted on . Women, but not men, at risk for or who have early dementia exhibited free carnitine deficiency. Free-carnitine ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Biomarker testing uses blood, saliva, or tissue to measure specific health metrics and provide insights into your body’s functioning.